Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06224556
Other study ID # PNRR-MAD-2022-12376781
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date February 1, 2024
Est. completion date May 2025

Study information

Verified date January 2024
Source Ente Ospedaliero Ospedali Galliera
Contact Alberto Pilotto
Phone 0039 0105634467
Email alberto.pilotto@galliera.it
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

- Non-Communicable Diseases (NCDs) can accelerated the aging process and increase the frailty condition - The Comprehensive Geriatric Assessment (CGA) is the gold standard in the geriatric clinical context - Recently, in Italy the first Guidelines about the CGA in different settings for older people has been pubblicated - The CGA can identify older people at high risk of frailty who can benefit from a personalized prevention program - No studies has been investigated the effects of a personalized prevention program (PPP) based on the CGA in a primary care setting - The main hypothesis is that the CGA assessment can result in personalized prevention programs for older subjects in primary care settings with an effect in reducing the hospitalization rate and can be related to the biological paramters in NCDs


Description:

The main aim of the project is to evaluate in older people the effectiveness of personalized preventive interventions based on the Comprehensive Geriatric Assessment (CGA) in the primary care setting and to explore biological process in Non-Communicable Disases (NCDs). The study involves 1216 subjects enrolled by General Practitioners (GPs) in four different Italian Areas. The GPs involved will be randomised to clusters in a 1:1 ratio, therefore one group of GPs will enrol patients for the Intervention Group and a second group of GPs will include patients for the Control Group. The sample size: A recent Cochrane systematic review reports a significant reduction in the risk of unplanned hospitalisation in community-dwelling elderly persons treated with VMD compared to standard clinical practice (RR= 0.83; CI 95%: 0.70-0.99). Thus, assuming an incidence of unplanned hospitalisations in one year of 38.8% in the group receiving PPP compared to 47.7% in the group randomised to standard care and assuming a power of 80% and a type I error of 5%, a total of 972 participants will be enrolled. Furthermore, assuming a drop-out rate of 20% over the 1-year follow-up period, the final sample will be 1216 participants, 608 in each group 608 subjects will be involved in the intervention group: they will receive the Personalized Prevention Program (PPP) and a saliva sample will be collected. 608 subjects will be involved in the control group according to the normal clinical practice. Both groups will be contacted at 6 and 12 months after the baseline for the follow-up. Statistical analyses: Baseline characteristics will be compared between the group receiving the CGA-based PPP intervention and the control group. Continuous variables will be compared using the t-Student test and categorical variables using the Chi-square test. The cumulative probability of the primary and secondary outcome will be estimated by Kaplan-Meier curve, using the log-rank test to assess differences between the two groups. To assess the risk associated with the primary outcome (rate of unplanned hospitalisation at 12 months) in subjects in the intervention group compared to subjects in standard care, the Hazard Ratio (HR) will be estimated by fitting a Cox model, after testing for proportional hazards. Similarly, the risk of secondary outcomes will be estimated.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 1216
Est. completion date May 2025
Est. primary completion date May 2025
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - 65 years old and over - At least 1 non-communicable chronic disease - Signed informed consent Exclusion Criteria: - not willing in partecipating in the study and no signed informed consent - <65 years old - without non-communicable chronic diseases

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
Brief-MPI assessment (based on the Comprehensive Geriatric Assessment); Personalized Prevention Program
Patients will be evaluated at baseline and at 6 and 12 months after the baseline through the CGA, the Resilience Scale (RS-14 items) and the Psychological General Wellbeing Index short form. The prevention program will be received at the baseline, so at the two follow-ups patients wiil asked the adherence to it and the level of satisfaction (Client Satisfaction Questionnaire - 8 items). Saliva sample will be collected and analyzed.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Alberto Pilotto

Outcome

Type Measure Description Time frame Safety issue
Other Adherence at the PPP Adherence at the Personalized Prevention Program by the Intervention Group 6 and 12 months
Other Psychological Well-being Psychological well-being assessed to the Intervention Group Baseline, 6 and 12 months
Other Resilience Resilience outcome evaluated in the Intervention Group Baseline, 6 and 12 months
Other Lactate in the Intervention Group Saliva analyses for the Lactate parameter After the saliva collection at the baseline
Other NAD/NADH in the Intervention Group Saliva analyses for theNAD/NADH parameter After the saliva collection at the baseline
Other TBARS in the Intervention Group Saliva analyses for the TBARS parameter After the saliva collection at the baseline
Other TNF-alfa in the Intervention Group Saliva analyses for theTNF-alfa parameter After the saliva collection at the baseline
Other IL-1b in the Intervention Group Saliva analyses for the IL-1b parameter After the saliva collection at the baseline
Other IL-6 in the Intervention Group Saliva analyses for the IL-6 parameter After the saliva collection at the baseline
Other IL-8 in the Intervention Group Saliva analyses for the IL-8 parameter After the saliva collection at the baseline
Other Microbioma saliva analysis in a sub-group of the Intervention Group The microbioma saliva sample will be analysed in 210 subjects from the Intervention Group through the DNA GENOTEK OME-505 Omnigene Oral Collection Kits for Nucleic Acid Saliva After the saliva collection at the baseline
Primary Hospitalization rate Unplanned hospitalization rate 12 months
Secondary Composed outcome Composed outcome including: emergency access rate, hospitalization and institutionalization rates at 6 and 12 months after the baseline. 6 and 12 months
Secondary Number of unplanned General Practitioners visits Unplanned GPs visits 12 months
Secondary Mortality rate mortality rate at 6 and 12 months 6 and 12 months
See also
  Status Clinical Trial Phase
Completed NCT05193773 - Effects of a Multifactorial Intervention to Reduce Physical Restraints for Care Providers in Nursing Homes N/A
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT04503811 - Sense of Control in Frail Older Persons
Completed NCT06320093 - Training Social and Health Care prOfessionals in mUsic-based Therapeutic iNterventions to Support Older People With Dementia N/A
Recruiting NCT06307197 - HAAL: HeAlthy Ageing Eco-system for peopLe With Dementia N/A
Completed NCT05626556 - A Technology-based Intervention to Support Older Adults in Living Independently N/A
Not yet recruiting NCT05859737 - Disaster Preparedness of Older People N/A
Completed NCT05144815 - Effectiveness of an Endurance Exercise Programme Preceded by Ischaemic Preconditioning in Older People N/A
Not yet recruiting NCT06419465 - The Effect of Health Protection and Promotion Training Programs on the Health Behavior of Older People N/A
Active, not recruiting NCT05963360 - Planning for Frailty: Optimal Health and Social Care Workforce Organisation Using Demand-led Simulation Modelling
Completed NCT04148196 - The Effect of Progressive Relaxation Exercise on Adaptation to Old Age and Quality of Life. N/A
Completed NCT05543538 - Influence of Different Teaching Strategies on the Academic Performance and Caring of Nursing Students N/A
Recruiting NCT05096507 - Cytokines, POD, Health Status, Older Hip Fracture
Active, not recruiting NCT03964311 - Risk for Short-term Adverse Events in Older Emergency Department Users N/A
Completed NCT04800731 - Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19
Recruiting NCT05367128 - Effects of Dual Task Prioritization Training on Dual Task Walking in Older People N/A
Completed NCT04019587 - Turkish Version of Fear of Falling Avoidance Behavior Questionnaire
Completed NCT05241886 - Evaluation of Sarcopenia With SARC-F and Anthropometric Measurement
Completed NCT04416503 - Effect of Reflexology on Diabetic Foot and Glycemic Control in Elderly Diabetic Individuals N/A
Completed NCT05532371 - The Effect of Exercise on Cognitive Status in Older Adults N/A